Texas 2019 - 86th Regular

Texas House Bill HB563

Caption

Relating to an acknowledgement on receipt of an opioid prescription drug.

Impact

The impact of HB 563 on state laws is significant, as it introduces a new requirement that pharmacists must comply with when dispensing opioids. By mandating the use of an acknowledgement form, the bill aims to ensure that patients are better informed about the dangers of opioids, which could lead to more conscientious use of these substances. Additionally, maintaining signed forms in pharmacists' records could enhance accountability and oversight, potentially reducing misuse and promoting safer handling of opioid prescriptions in Texas.

Summary

House Bill 563 aims to amend the Health and Safety Code by establishing requirements for pharmacists regarding the dispensing of opioid prescriptions. Specifically, the bill mandates that pharmacists provide a written acknowledgement form to individuals receiving opioid medications. This form serves to inform patients about the risks associated with opioid use, including the potential for addiction and overdose. The bill seeks to enhance awareness and promote safer prescribing practices in the context of the opioid epidemic affecting many communities.

Contention

There may be points of contention regarding the practical implications of this bill. Some critics could argue that the added burden on pharmacists could create challenges in the dispensing process, especially in high-volume pharmacy settings. Concerns might also arise about ensuring that patients fully understand the acknowledgement form and its contents before signing. Proponents of the bill may counter that the benefits of raising awareness about opioid risks outweigh the administrative burdens associated with compliance.

Companion Bills

No companion bills found.

Previously Filed As

TX HB814

Relating to an acknowledgment on receipt of an opioid prescription drug.

TX HB972

Relating to warning labels for opioid prescription drugs.

TX HB816

Relating to warning labels for opioid prescription drugs.

TX HB815

Relating to distinctive packaging for opioid prescription drugs.

TX HB5230

Relating to health benefit plan coverage of prescription drugs for serious mental illnesses and opioid and substance use disorders.

TX HB2411

Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.

TX SB629

Relating to the maintenance, administration, and disposal of opioid antagonists on public and private school campuses and to the permissible uses of money appropriated to a state agency from the opioid abatement account.

TX SB2173

Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.

TX HB3338

Relating to measures to prevent and respond to opioid-related drug overdoses, including policies and training regarding the use of opioid antagonists, at student residences on campuses of public institutions of higher education; providing immunity.

TX HB343

Relating to the prescriptive authority of certain psychologists; authorizing a fee.

Similar Bills

CA SB1286

Pharmacy technicians.

CA AB1589

Pharmacy: pharmacist supervision: technicians.

CA SB339

HIV preexposure prophylaxis and postexposure prophylaxis.

CA SB1365

Pharmacy technicians: supervision.

CA SB476

Pharmacy: Pharmacist Employer Advisory Task Force.

CA SB655

Pharmacy.

NJ S1965

Regulates provision of pharmaceutical services in long-term care facilities.

NJ A5248

Regulates provision of pharmaceutical services in nursing homes.